Oral anticoagulants--the totem and the taboo.
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000983:Antipyrine / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D002697:Chloral Hydrate / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D004790:Enzyme Induction / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008099:Liver / Q000378:metabolism; D009203:Myocardial Infarction / Q000188:drug therapy; D051381:Rats; D012107:Research Design; D014812:Vitamin K / Q000378:metabolism; D014859:Warfarin / Q000097:blood / Q000378:metabolism
D000925:Anticoagulants; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D014812:Vitamin K; D002697:Chloral Hydrate; D014859:Warfarin; D000983:Antipyrine